Yaping J. Yang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: November 14, 2025
De-escalation of axillary surgery after neoadjuvant therapy in breast cancer: long-term outcomes of sentinel lymph node biopsy alone versus complete axillary lymph node dissection.
Journal: Therapeutic advances in medical oncology
Published: September 27, 2025
Correction: IHC4 and COMBINE scores for enhanced prognostic stratification in HR+/HER2- breast cancer patients after neoadjuvant chemotherapy.
Journal: Breast cancer research and treatment
Published: September 25, 2025
Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trial.
Journal: BMJ (Clinical research ed.)
Published: September 11, 2025
Fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER2-negative metastatic breast cancer after first-line chemotherapy (FAMILY): a multicenter, open-label, randomized, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: September 04, 2025
Effects of radiotherapy in borderline and malignant phyllodes tumors after R0 resection: a propensity score analysis.
Journal: Therapeutic advances in medical oncology
Published: April 10, 2025
Evolution of VOx on TiO2-ZSM-5 Composite Supports upon K Poisoning and Its Effects on Ultralow Temperature NH3-SCR.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: March 05, 2025
Impact of intraoperative radiotherapy vs. whole-breast external beam radiotherapy for early breast cancer: a propensity score matching study based on SEER database.
Journal: Gland surgery
Published: February 09, 2025
IHC4 and COMBINE scores for enhanced prognostic stratification in HR+/HER2- breast cancer patients after neoadjuvant chemotherapy.
Journal: Breast cancer research and treatment
Published: December 28, 2024
Safety and Efficacy of KN046 in Combination with KN026 in Patients with Advanced HER2-Positive Breast Cancer: A Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 26, 2024
MMP1-induced NF-κB activation promotes epithelial-mesenchymal transition and sacituzumab govitecan resistance in hormone receptor-positive breast cancer.
Journal: Cell death & disease
Published: September 07, 2024
Last Updated: 09/26/2026